Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.
Semin Cell Dev Biol. 2010 Sep;21(7):691-8. doi: 10.1016/j.semcdb.2010.02.008. Epub 2010 Feb 24.
Autophagy is an intracellular degradation process responsible for the clearance of most long-lived proteins and organelles. Cytoplasmic components are enclosed by double-membrane autophagosomes, which subsequently fuse with lysosomes for degradation. Autophagy dysfunction may contribute to the pathology of various neurodegenerative disorders, which manifest abnormal protein accumulation. As autophagy induction enhances the clearance of aggregate-prone intracytoplasmic proteins that cause neurodegeneration (like mutant huntingtin, tau and ataxin 3) and confers cytoprotective roles in cell and animal models, upregulating autophagy may be a tractable therapeutic strategy for diseases caused by such proteins. Here, we will review the molecular machinery of autophagy and its role in neurodegenerative diseases. Drugs and associated signalling pathways that may be targeted for pharmacological induction of autophagy will also be discussed.
自噬是一种负责清除大多数寿命长的蛋白质和细胞器的细胞内降解过程。细胞质成分被双层膜自噬体包裹,随后与溶酶体融合进行降解。自噬功能障碍可能导致各种神经退行性疾病的病理发生,表现为异常蛋白质积累。由于自噬诱导增强了对引起神经退行性变的聚集倾向细胞内蛋白质(如突变 huntingtin、tau 和 ataxin 3)的清除,并在细胞和动物模型中发挥细胞保护作用,上调自噬可能是治疗此类蛋白质引起的疾病的一种可行的治疗策略。在这里,我们将回顾自噬的分子机制及其在神经退行性疾病中的作用。还将讨论可能作为药理学诱导自噬的靶点的药物和相关信号通路。